R&D

Most leaders tune out when they hear “tax credit.” That may be a mistake. R&D credits have quietly expanded and can unlock real strategic value for life sciences companies. I’ve spent enough time in boardrooms and leadership meetings to know that when someone says “tax credit,” most ears glaze over. It’s the kind of topic that lands squarely in the important but not urgent bucket. And yet, the conversations I’ve been having lately with experts in the life sciences are making me rethink that instinct.